Delivery Order SPE2DB22D3011-SPE2DB25FQ2QV
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,815.80 for Dexmethylphenidate ER 10 mg capsules (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dexmethylphenidate is a central nervous system stimulant commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a contract value of $1,468.47. This firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award for pharmaceutical supplies to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order valued at $3,971.57 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with an ultimate completion date of August 13, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,226.04. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for Dexmethylphenidate ER 10 mg capsules in a quantity of 100 units at a ceiling value of $3,265.34. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, reflecting the vendor's established capability to meet federal pharmaceutical procurement requirements through open competition. The contract will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) valued at $3,238.65. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The contract calls for ultimate completion by July 28, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 20 mg capsules (100-count) valued at $3,244.14 under a firm fixed price contract. The award, made on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,169.62 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 10 mg capsules (100 count). The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,433.30 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 20 mg capsules (100 count) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 15 mg capsules (100 count) valued at $2,024.24, with a performance period through August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor at its Conshohocken, Pennsylvania corporate office location. The award represents a pediatric neurological medication commonly used to treat attention deficit...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2QVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 30 mg capsules (100 count) valued at $1,722.69, with an ultimate completion date of September 10, 2025. This is a firm fixed-price, non-set-aside contract utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Dexmethylphenidate is a prescription medication commonly used to treat attention deficit hyperactivity disorder, indicating this delivery supports military or federal healthcare supply requirements. This delivery order represents a small-value transaction under AmerisourceBergen's substantial $1 billion IDC vehicle with DLA Troop Support Medical, which runs through December 2026 and provides comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability in fulfilling federal medical procurement needs through competitive awards. The company supplies an extensive range of pharmaceutical products and medical commodities to support Defense Health Agency operations and other federal healthcare systems, with this particular order exemplifying routine pharmaceutical resupply activities under the broader prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/9/25 |